Package 1 - Report (inc. Market Sizing Analysis) - £1499

A digital copy of the report which includes an assessment of the market size within the pharmaceutical cannabis industry, conducted by Prohibition Partners, which primarily consists of three cannabinoid treatments: Epidiolex, dronabinol, and Sativex. The impact of Syndros, Marinol, nabilone and Cesamet/Canemes on the overall figures is of little significance – collectively, these medications are projected to contribute less than US$3 million in 2023, representing less than 0.3% of the global sales. For this reason, they have not been included in the charts in this section.

Package 2 - Report (inc. Market Sizing Analysis) + 2-Hour Analyst Consultation - £2399

A digital copy of the report which includes an assessment of the market size within the pharmaceutical cannabis industry (as described above). This package also includes a 2-hour consultation with one of Prohibition Partners' senior analysts. This consultation can cover key findings of the report and additional insight. This is a bespoke consultation and can be tailored to your needs.

Package 3 - Clinical Trials Database - £749

This is a comprehensive list of clinical trials involving cannabis and cannabinoids taking place since 2010. The total number of clinical trials contained in the dataset is 440. For each clinical trial listed, the following information is given:

• NCT Number
• Study Title
• Study URL (Clinicaltrials.gov)
• Study Status
• Phase(s)
• Primary Condition
• Type of Pain (Pain Only)
• Conditions (Extended)
• Intervention
• Treatment Used:
  • CBD Only (yes/no)
  • THC Only (yes/no)
  • Both THC + CBD (yes/no)
  • Epidiolex (yes/no)
  • Sativex (yes/no)
  • Dronabinol (yes/no)
  • Nabilone (yes/no)
• Primary Outcome Measures
• Sponsor
• Collaborators
• Study Type
• Locations
• Start Date
• Status

Package 4 - Patent Portfolio - £699

This is a comprehensive review of the patent portfolios of Jazz Pharmaceuticals Ltd. (split into those held by GW Research Ltd., and those held by GW Pharmaceuticals Ltd.), and of six other leading companies involved in patenting activity for the medical application of cannabis and cannabinoids.

The dataset consists of unique patent families or “novel inventions” - meaning the same patent filed in multiple locations or at different times.

The date shown is that at which the first patent in each patent family is believed to have been applied for. There are no URLs or links to the patents included in the dataset.

Key terms related to these patents were extrapolated from analysing their content, and in each case, the terms which are relevant to each individual patent family are marked. Examples of key terms include:

• CBD
• CBDA
• CBDV
• THC
• THCA
• THCV
• Epilepsy
• Neuroprotection
• Neurodegeneration
• Arthritis
• CBD Analogue
• Manufacturing Methodology
• Novel Compound
• Brain Injury

Package 5 - Report (inc. Market Sizing), 2-Hour Analyst Consultation, Clinical Trials Database + Patent Portfolio - £3299

Save over £500 by purchasing all of the above in a single package.